Quality problems delay start of controlled cannabis sales in Basel
The «Weed Care» pilot project in the city of Basel was supposed to launch today and understand to supply 370 people with cannabis for 2.5 years. It was put on hold because traces of pesticides were found in some of the supposedly organic plants.
The Basel health department stated that the delay could last several weeks, even months, as the products now need to be re-analyzed by an independent body.
Six products—four types of cannabis flowers and two types of hashish—were supposed to go on sale in nine pharmacies starting this week.

Participants will be able to legally purchase these six products during the pilot project – Credit Pure Holdings AG
The Federal Office of Public Health has approved the pilot project last April as part of a project led by the University of Basel, its psychiatric clinics, and the cantonal health department.
It should allow for the evaluation of effects of the new regulation on recreational cannabis use and, in the long term, to combat black market distribution.
Several other local authorities, including Zurich, Biel, Geneva, and Bern, also put themselves forward as candidates to conduct similar trials. The Swiss Parliament laid the legal groundwork for such small-scale initiatives in September 2020.
The Basel pilot, which will allow 370 people to participate in the sale of approved products, received 700 applications.
The Basel health authorities will now consider options, including other products from the same supplier or other suppliers.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login